Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia

Helicobacter

Volumn 18, Issue 2, 2013, Pages 151-157

  Quach, Duc Trong ^a   Le, Huy Minh ^a   Hiyama, Toru ^b   Nguyen, Oanh Thuy ^a   Nguyen, Trung Sao ^a   Uemura, Naomi ^c  

^a Ho Chi Minh University of Technology   (Viet Nam)

^b HIROSHIMA UNIVERSITY   (Japan)

^c National Center for Global Health and Medicine   (Japan)

Author keywords

Dysplasia; Endoscopic gastric atrophy; Intestinal metaplasia; Operative Link on Gastritis Assessment gastritis stage

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPEPSIA; ENDOSCOPY; FEMALE; GASTRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ATROPHY; STOMACH BIOPSY; VIET NAM;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84875042720     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12027     Document Type: Article

References (28)

1. Correa P. Is gastric cancer preventable? Gut 2004;53:1217-9.
2. De Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945-52.
3. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000;95:1431-8.
4. Filipe MI, Munoz N, Matko I, Kota I, Pompe-Kirn V, Jutersek A, Teuchmann S, Benz M, Prijon T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
5. Hosokawa O, Watanabe K, Hatorri M, Douden K, Hayashi H, Kaizaki Y. Detection of gastric cancer by repeat endoscopy within a short time after negative examination. Endoscopy 2001;33:301-5.
6. Rokkas T, Filipe M, Sladen G. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991;32:1110-3.
7. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631-6.
8. Satoh K, Osawa H, Yoshizawa M, Nakano H, Hirasawa T, Kihira K, Sugano K. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008;13:225-9.
9. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007;42(Suppl. XVII):21-7.
10. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
11. Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic gastric atrophy could help to predict OLGA gastritis stage. J Gastroenterol Hepatol 2011;26:281-5.
12. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;3:87-97.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
14. Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-8.
15. Dixon M. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002;51:130-1.
16. Quach DT. Evaluation of a local rapid urease test for Helicobacter pylori diagnosis in comparison with PyloriTek (abstract). J Gastroenterol Hepatol 2006;21(Suppl. 6):A391.
17. 14C-urea breath test and local rapid urease test in accessing the H. pylori status after eradication. Vietnamese J Gastroenterol 2008;3:659-63 (Vietnamese).
18. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann Intern Med 2009;151:121-8.
19. Sakaki N, Kozawa H, Egawa N, Tu Y, Sanaka M. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment Pharmacol Ther 2002;16(Suppl. 2):198-203.
20. Ahn SY, Lee SY, Hong SN, Kim JH, Sung IK, Park HS, Shim CS, Jin CJ, Han HS. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and cdx2 expression. Dig Dis Sci 2011;56:1119-26.
21. Wu MS, Shunt CT, Lee WC, Chen CJ, Wang HP, Lee WJ, Lin JT. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Br J Cancer 1998;78:125-8.
22. El-Zimaity H, Graham D. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 1999;30:72-7.
23. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Moreira-Dias L. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2007;22:1594-604.
24. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004;53:1244-9.
25. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378-81.
26. Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46.
27. Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, Haruma K. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol 2007;42:760-4.
28. Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405-14.